​Telomeres, Senolytics, and an Anti-Aging Experiment: Bill Andrews of Sierra Sciences

posted in: Biotechnology | 0

Dr. Bill Andrews is the Founder and CEO of Sierra Sciences, a company focused on finding ways to extend human lifespan and health span through telomere maintenance. Telomeres are found at the tips of our chromosomes and have been shown, in thousands of scientific peer-reviewed studies, to be the clock of aging in humans. When telomeres get shorter, we get older, and our health declines. As a scientist, athlete and executive, Bill continually pushes the envelope and challenges convention. He has been featured in Popular Science, The Today Show and numerous … Read More

Looking in the Mirror: Beyond Superficial AI Ethics, A Discussion with Gisele Waters

posted in: Biotechnology | 0

Gisele Waters, Ph.D. is an innovation psychologist and researcher. To inform the promise and challenge of innovating human and machine integrations such as artificial intelligence and blockchain into healthcare and the life sciences; she draws from a Ph.D. In Education Psychology, M.Ed. in Special Education, a B.A. in Economics and 25 plus years of multidisciplinary success in education, business, and science. Her bandwidth extends to being a multimillion dollar Texas real estate broker and education advisor to startups in healthcare, … Read More

Our Unseen Reality: The Relativistic Transactional Interpretation of Quantum Mechanics with Ruth Kastner

posted in: Biotechnology | 0

Ruth E. Kastner earned her M.S. in Physics and Ph.D. in Philosophy (History and Philosophy of Science) and the University of Maryland, College Park (1999). She has taught a variety of philosophy and physics courses throughout the Baltimore-Washington corridor, and currently is a member of the Foundations of Physics group at UMCP. She is also an Affiliate of the physics department at the SUNY Albany campus. She specializes in time-symmetry and the Transactional Interpretation (TI) of quantum mechanics, and in particular has extended … Read More

The Best of Blockchain: Joseph Snyder and Chris Brown of Lannister Holdings

posted in: Biotechnology | 0

Lannister Holdings, Inc., an Arizona company, is currently trading under the Symbol NBDR on the US OTC Market. We will use @LannisterNBDR Twitter account for announcements moving forward. Dedicated to being the world’s premier US based blockchain development firm, Lannister Development will build bespoke systems for clients around the world while deploying, testing, and globally protecting the systems and technologies vital to our internal focus of facilitating real estate finance on blockchain.

The Fastest Growing Company in America: A Conversation with Jason Swanson, Cofounder of SwanLeap

posted in: Biotechnology | 0

“The world’s ruling structure has been reset. The future of chaos awaits!” – Hououin Kyouma To say that I am a passionate entrepreneur only works if you make sure to add that I am known to be a bit of mad scientist as well. People would laugh when I told them I would change the shipping industry for good and make it possible for everyone to have what they really wanted: TRANSPARENCY on everything. Now, look! We have grown this … Read More

Raising the Dead? BioQuark and the ReAnima Project with Ira Pastor

posted in: Biotechnology | 0

Ira Pastor – Chief Executive Officer – Bioquark Inc. – 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail. Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development; Prior to that, employed by SmithKline Beecham Pharmaceuticals working in sales, … Read More

Breast Cancer, Bioprinting, and Breast Reconstruction with Laura Bosworth of TeVido

posted in: Biotechnology | 0

Laura Bosworth, CEO and co-founder of TeVido BioDevices, is a dynamic former Fortune 50 executive with 25+ years of cross-functional industry experience. TeVido is a biotech start-up using innovative 3D bioprinting and a woman’s own cells to create tissue engineered solutions for reconstruction after breast cancer. Recent press coverage includes CNBC, CNN, The Economist, Popular Science and many more. The company has received grants from the National Science Foundation, the National Cancer Institute and the LIVESTRONG Foundation. With a B.S. in … Read More

Biotech Trends with Joachim Eeckhout of Labiotech.eu

posted in: Biotechnology | 0

Joachim is the co-founder & COO of Labiotech.eu, the leading digital media covering the European Biotech industry. It is used by over 15,000 people monthly to keep a watch on the business and innovations of biotechnologies. Join them for free and enjoy reading our stories! Take a look at his website and feel free to contact him. It will be a pleasure to talk with you about biotechnologies and entrepreneurship! mRNA Therapies: CureVac Outperformed the Money Magnet Moderna Servier http://labiotech.eu/how-servier-saved-cellectis-the-french-car-t-miracle/ … Read More

Emerging Trends in Biotechnology: Adam Alonzi and Gennady Stolyarov

posted in: Biotechnology | 0

In this episode Gennady Stolyarov II interviews me about some of my guests and current trends in biotechnology. Here I am in the hot seat! We cover gene therapy, nanotechnology, work I have done in nanotech, bioprinting, regenerative medicine, the legal landscape, existential threats posed by biohacking, and the ways in which the DIY revolution is changing biology. Music by Andrew Vavrek of Tryad.